Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-22
1995-11-21
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548126, A61K 3146, C07D45112
Patent
active
054687586
ABSTRACT:
Crystalline and pharmacologically active monohydrates of endo-2,3-dihydro-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2-oxo-1H-benzimi dazole-1-carboxamide hydrochloride and of endo-3-ethyl-2,3-dihydro-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2-oxo-1H -benzimidazole-1-carboxamide hydrochloride.
REFERENCES:
patent: 5223511 (1993-06-01), Turconi et al.
Sagrada, A; Turconi, M.; Bonali, P.; Schiantarelli, P., Micheletti, R.; Montagna, E; Nicolam M.; Algate, D. R.; Rimoldi, E. M.; and Donetti, A. Cancer Chemother. Pharmacol. (1991) 28:470-474.
Cereda Enzo
Dubini Enrica
Ezhaya Antoine
Maffione Grazia
Turconi Marco
Boehringer Ingelheim Italia S.p.A.
Devlin Mary-Ellen
Raymond Robert P.
Richter Johann
Stempel Alan R.
LandOfFree
Crystalline forms of endo-2,3-dihydro-N-(8-methyl)-8-azabicyclo[ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of endo-2,3-dihydro-N-(8-methyl)-8-azabicyclo[, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of endo-2,3-dihydro-N-(8-methyl)-8-azabicyclo[ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137389